Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tissue plasminogen activator |
Is a |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Single chain urokinase-like plasminogen activator (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Poisoning by urokinase |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental urokinase poisoning |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional urokinase poisoning |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
forgiftning med urokinase, uvist med hvilken hensigt |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Allergy to urokinase (finding) |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Urokinase overdose |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental urokinase overdose |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional urokinase overdose |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af urokinase, uvist med hvilken hensigt |
Causative agent |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing urokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
urokinase 50.000 enheder/ml injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Urokinase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Anistreplase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Streptokinase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing plasminogen activator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Product containing anistreplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing streptokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 1,5 MIE pulver til infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 250.000 IE pulver til infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 750.000 IE pulver til infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing urokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 100.000 enheder + streptodornase 25.000 enheder pulver til topikal anvendelse + kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase + streptodornase 100.000/25.000 enheder pulver til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Urokinase 5000 unit/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing streptodornase and streptokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
anistreplase 300 enheder/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
urokinase 50.000 enheder/ml injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 600.000 IE/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 750.000 enheder infusionsvæske til intravenøs anvendelse, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 1,5 MIE infusionsvæske, opløsning, til intravenøs anvendelse, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
streptokinase 250.000 enheder infusionsvæske til intravenøs anvendelse, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Tenecteplase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Alteplase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|
Reteplase (substance) |
Is a |
True |
Substance with plasminogen activator mechanism of action (substance) |
Inferred relationship |
Some |
|